Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSpinnaker Trust
Latest Disclosed Ownership1,959 shares
Latest Disclosed Value $ 299,237
Spinnaker Trust ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 23, 2026 - Spinnaker Trust filed a 13F-HR form disclosing ownership of 1,959 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $299,237 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,959 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $281,430 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F Novartis AG ADR Equities 66987V109 1,959 0 0.00 299 10.74 0.0166
2026-02-10 2025-12-31 13F Novartis AG ADR Equities 66987V109 1,959 0 0.00 270 7.57 0.0145
2025-11-05 2025-09-30 13F Novartis AG ADR Equities 66987V109 1,959 0 0.00 251 5.91 0.0139
2025-08-04 2025-06-30 13F Novartis AG ADR Equities 66987V109 1,959 1,959 237 0.0143
2025-01-30 2024-12-31 13F Novartis AG ADR Equities 66987V109 0 -1,759 -100.00 0 -100.00
2024-10-31 2024-09-30 13F Novartis AG ADR Equities 66987V109 1,759 1,759 202 0.0125
2024-02-02 2023-12-31 13F Novartis AG ADR Equities 66987V109 0 -2,059 -100.00 0 -100.00
2023-11-08 2023-09-30 13F Novartis AG ADR Equities 66987V109 2,059 0 0.00 210 0.97 0.0158
2023-08-01 2023-06-30 13F Novartis AG ADR Equities 66987V109 2,059 2,059 208 0.0151
2023-04-13 2023-03-31 13F Novartis AG ADR Equities 66987V109 0 -4,504 -100.00 0 0.0000
2023-02-02 2022-12-31 13F Novartis AG ADR Equities 66987V109 4,504 -216 -4.58 0 -100.00 0.0318
2022-10-28 2022-09-30 13F Novartis AG ADR Equities 66987V109 4,720 0 0.00 359 -10.03 0.0298
2022-07-25 2022-06-30 13F Novartis AG ADR Equities 66987V109 4,720 334 7.62 399 3.64 0.0308
2022-05-02 2022-03-31 13F Novartis AG ADR Equities 66987V109 4,386 -475 -9.77 385 -9.62 0.0260
2022-01-31 2021-12-31 13F Novartis AG ADR Equities 66987V109 4,861 0 0.00 426 7.04 0.0273
2021-11-02 2021-09-30 13F Novartis AG ADR Equities 66987V109 4,861 0 0.00 398 -10.16 0.0277
2021-08-09 2021-06-30 13F Novartis AG ADR Equities 66987V109 4,861 -200 -3.95 443 2.55 0.0309
2021-04-30 2021-03-31 13F Novartis AG ADR Equities 66987V109 5,061 692 15.84 432 5.11 0.0324
2021-01-26 2020-12-31 13F Novartis AG ADR Equities 66987V109 4,369 0 0.00 411 8.44 0.0328
2020-10-27 2020-09-30 13F Novartis AG ADR Equities 66987V109 4,369 0 0.00 379 -0.52 0.0336
2020-07-21 2020-06-30 13F Novartis AG ADR Equities 66987V109 4,369 156 3.70 381 9.80 0.0361
2020-05-05 2020-03-31 13F Novartis AG ADR Equities 66987V109 4,213 670 18.91 347 3.58 0.0382
2020-02-05 2019-12-31 13F Novartis AG ADR Equities 66987V109 3,543 -710 -16.69 335 -9.21 0.0306
2019-11-12 2019-09-30 13F Novartis AG ADR Equities 66987V109 4,253 515 13.78 369 8.53 0.0364
2019-07-11 2019-06-30 13F Novartis AG ADR Equities 66987V109 3,738 -206 -5.22 340 -10.05 0.0341
2019-04-29 2019-03-31 13F Novartis AG ADR Equities 66987V109 3,944 0 0.00 378 11.83 0.0380
2019-02-04 2018-12-31 13F Novartis AG ADR Equities 66987V109 3,944 0 0.00 338 -0.29 0.0384
2018-10-23 2018-09-30 13F Novartis AG ADR Equities 66987V109 3,944 1,081 37.76 339 57.67 0.0335
2018-08-02 2018-06-30 13F Novartis AG ADR Equities 66987V109 2,863 14 0.49 215 -6.11 0.0229
2018-05-10 2018-03-31 13F Novartis AG ADR Equities 66987V109 2,849 -98 -3.33 229 -7.29 0.0249
2018-02-09 2017-12-31 13F Novartis AG ADR Equities 66987V109 2,947 0 0.00 247 -1.98 0.0287
2017-10-26 2017-09-30 13F Novartis AG ADR Equities 66987V109 2,947 0 0.00 252 2.44 0.0315
2017-07-27 2017-06-30 13F Novartis AG ADR Com 66987V109 2,947 0 0.00 246 12.33 0.0307
2017-05-10 2017-03-31 13F Novartis AG ADR Com 66987V109 2,947 -7,963 -72.99 219 -72.45 0.0285
2017-02-15 2016-12-31 13F Novartis AG ADR Com 66987V109 10,910 5,888 117.24 795 118.41 0.1069
2016-11-03 2016-09-30 13F Novartis AG ADR Com 66987V109 5,022 -7,632 -60.31 364 -65.13 0.0511
2016-08-01 2016-06-30 13F Novartis AG ADR Com 66987V109 12,654 7,632 151.97 1,044 186.81 0.1439
2016-05-05 2016-03-31 13F Novartis AG ADR Com 66987V109 5,022 0 0.00 364 -15.74 0.0511
2016-01-29 2015-12-31 13F Novartis AG ADR Com 66987V109 5,022 0 0.00 432 -6.49 0.0617
2015-11-06 2015-09-30 13F Novartis AG ADR Com 66987V109 5,022 0 0.00 462 -6.48 0.0707
2015-08-05 2015-06-30 13F Novartis AG ADR Com 66987V109 5,022 138 2.83 494 2.49 0.0737
2015-04-17 2015-03-31 13F Novartis AG ADR Com 66987V109 4,884 304 6.64 482 13.68 0.0696
2015-01-22 2014-12-31 13F Novartis AG ADR Com 66987V109 4,580 430 10.36 424 8.44 0.0630
2014-11-03 2014-09-30 13F Novartis AG ADR Com 66987V109 4,150 -1,625 -28.14 391 -25.24 0.0631
2014-07-28 2014-06-30 13F Novartis AG ADR Com 66987V109 5,775 -3,714 -39.14 523 -35.19 0.0857
2014-04-23 2014-03-31 13F Novartis AG ADR Com 66987V109 9,489 0 0.00 807 5.91 0.1327
2014-01-24 2013-12-31 13F Novartis AG ADR Com 66987V109 9,489 -70 -0.73 762 3.96 0.1269
2013-10-28 2013-09-30 13F Novartis AG ADR Com 66987V109 9,559 0 0.00 733 8.43 0.1328
2013-08-08 2013-06-30 13F Novartis AG ADR Com 66987V109 9,559 9,559 676 0.1272
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.